N-3 PUFAs reduce oxidative stress in ESRD patients on maintenance HD by inhibiting 5-lipoxygenase activity
- 1 April 2006
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 69 (8) , 1450-1454
- https://doi.org/10.1038/sj.ki.5000291
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal diseaseKidney International, 2003
- Vitamin E Supplementation Increases LDL Resistance to ex vivo Oxidation in Hemodialysis PatientsInternational Journal for Vitamin and Nutrition Research, 2003
- 5-Lipoxygenase-mediated mitochondrial damage and apoptosis of mononuclear cells in ESRD patientsKidney International, 2003
- Vitamin E suppresses 5-lipoxygenase-mediated oxidative stress in peripheral blood mononuclear cells of hemodialysis patients regardless of administration routeAmerican Journal of Kidney Diseases, 2001
- Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriageThe Lancet, 2000
- Induction of apoptosis by bleomycin in resting and cycling human lymphocytesMutagenesis, 1998
- Involvement of 5-lipoxygenase in programmed cell death of cancer cellsCell Death & Differentiation, 1997
- Studies on the Regulation and Localization of 5‐Lipoxygenase in Human B‐LymphocytesEuropean Journal of Biochemistry, 1995
- Cardiovascular Effects of n-3 Fatty AcidsNew England Journal of Medicine, 1988
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976